sodium oxybate
Generic: sodium oxybate
Labeler: amneal pharmaceuticals llcDrug Facts
Product Profile
Brand Name
sodium oxybate
Generic Name
sodium oxybate
Labeler
amneal pharmaceuticals llc
Dosage Form
SOLUTION
Routes
Active Ingredients
sodium oxybate 500 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
65162-065
Product ID
65162-065_fb0e7d54-bf58-46d7-8561-9a270771f0d2
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA203631
DEA Schedule
ciii
Listing Expiration
2027-12-31
Marketing Start
2025-09-12
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
65162065
Hyphenated Format
65162-065
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
sodium oxybate (source: ndc)
Generic Name
sodium oxybate (source: ndc)
Application Number
ANDA203631 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 500 mg/mL
Packaging
- 1 BOTTLE in 1 CARTON (65162-065-87) / 180 mL in 1 BOTTLE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "fb0e7d54-bf58-46d7-8561-9a270771f0d2", "openfda": {"upc": ["0365162065879"], "unii": ["7G33012534"], "rxcui": ["349482"], "spl_set_id": ["5a9e9045-f04d-46eb-8396-2495c6090a31"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (65162-065-87) / 180 mL in 1 BOTTLE", "package_ndc": "65162-065-87", "marketing_start_date": "20250912"}], "brand_name": "Sodium Oxybate", "product_id": "65162-065_fb0e7d54-bf58-46d7-8561-9a270771f0d2", "dosage_form": "SOLUTION", "pharm_class": ["Central Nervous System Depressant [EPC]", "Central Nervous System Depression [PE]", "Decreased Central Nervous System Organized Electrical Activity [PE]"], "product_ndc": "65162-065", "dea_schedule": "CIII", "generic_name": "Sodium Oxybate", "labeler_name": "Amneal Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Sodium Oxybate", "active_ingredients": [{"name": "SODIUM OXYBATE", "strength": "500 mg/mL"}], "application_number": "ANDA203631", "marketing_category": "ANDA", "marketing_start_date": "20250912", "listing_expiration_date": "20271231"}